CO6382158A2 - Síntesis de novedosas formas de sales de (r)-3-((e)-2-(pirrolidin-3-il)vinil)-5-(tetrahidropiran-4-iloxi)piridina - Google Patents
Síntesis de novedosas formas de sales de (r)-3-((e)-2-(pirrolidin-3-il)vinil)-5-(tetrahidropiran-4-iloxi)piridinaInfo
- Publication number
- CO6382158A2 CO6382158A2 CO11075843A CO11075843A CO6382158A2 CO 6382158 A2 CO6382158 A2 CO 6382158A2 CO 11075843 A CO11075843 A CO 11075843A CO 11075843 A CO11075843 A CO 11075843A CO 6382158 A2 CO6382158 A2 CO 6382158A2
- Authority
- CO
- Colombia
- Prior art keywords
- vinyl
- tetrahidropiran
- piridina
- iloxi
- pirrolidin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
La presente invención se refiere a (R)-3-(E)-2-(pirrolidin-3-il)vinil)-5-(tetrahidropiran-4-iloxi)piridina, sus formas de sales, y a procesos para la producción a escala comercial de estos compuestos en pureza y calidad suficientes para uso en composiciones farmacéuticas. Además, la presente invención concierne al uso de este compuesto en la fabricación de un medicamento para el tratamiento de trastornos relacionados con el sistema nervioso central (SNC).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11888508P | 2008-12-01 | 2008-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6382158A2 true CO6382158A2 (es) | 2012-02-15 |
Family
ID=41549744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11075843A CO6382158A2 (es) | 2008-12-01 | 2011-06-17 | Síntesis de novedosas formas de sales de (r)-3-((e)-2-(pirrolidin-3-il)vinil)-5-(tetrahidropiran-4-iloxi)piridina |
Country Status (28)
Country | Link |
---|---|
US (3) | US8633227B2 (es) |
EP (3) | EP2358670B1 (es) |
JP (2) | JP5698673B2 (es) |
KR (2) | KR20110094318A (es) |
CN (2) | CN102232072B (es) |
AR (1) | AR074239A1 (es) |
AU (2) | AU2009322628A1 (es) |
BR (2) | BRPI0922152A2 (es) |
CA (2) | CA2744197A1 (es) |
CL (2) | CL2009002145A1 (es) |
CO (1) | CO6382158A2 (es) |
EA (1) | EA021054B1 (es) |
EC (1) | ECSP11011135A (es) |
ES (1) | ES2403022T3 (es) |
HK (1) | HK1157778A1 (es) |
IL (2) | IL212796A0 (es) |
MX (2) | MX2011005712A (es) |
MY (1) | MY159040A (es) |
NZ (1) | NZ593058A (es) |
PE (1) | PE20100467A1 (es) |
RU (1) | RU2507197C2 (es) |
SA (1) | SA109300715B1 (es) |
SG (2) | SG171432A1 (es) |
TW (1) | TW201024283A (es) |
UA (1) | UA106217C2 (es) |
UY (1) | UY32278A (es) |
WO (2) | WO2010065447A2 (es) |
ZA (1) | ZA201103497B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9145396B2 (en) | 2008-12-01 | 2015-09-29 | Targacept, Inc. | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine |
WO2010065443A1 (en) * | 2008-12-01 | 2010-06-10 | Targacept, Inc. | Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine |
WO2013116371A1 (en) * | 2012-01-30 | 2013-08-08 | Roar Biomedical Inc. | Ex vivo plasma enzyme activity assay using inhibitors as a negative control |
AP2015008579A0 (en) | 2013-02-05 | 2015-07-31 | Purdue Pharma Lp | Tamper resistant pharmaceutical formulations |
US20160262372A1 (en) * | 2015-03-13 | 2016-09-15 | Cornell Kunz | Extermination Treatment Appliance And Method |
KR102485299B1 (ko) | 2016-04-07 | 2023-01-06 | 오이스터 포인트 파마 인코포레이티드 | 안구 장애의 치료 방법 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK94393A3 (en) * | 1992-09-11 | 1994-08-10 | Thomae Gmbh Dr K | Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those |
IL107184A (en) | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
US5852041A (en) | 1993-04-07 | 1998-12-22 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acethylcholine receptors |
US5597919A (en) | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
US5604231A (en) | 1995-01-06 | 1997-02-18 | Smith; Carr J. | Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
JP3745433B2 (ja) * | 1995-02-02 | 2006-02-15 | 第一製薬株式会社 | 複素環式化合物 |
US5585388A (en) | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
US5583140A (en) | 1995-05-17 | 1996-12-10 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of central nervous system disorders |
IL118279A (en) | 1995-06-07 | 2006-10-05 | Abbott Lab | Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission |
ID22045A (id) * | 1996-09-13 | 1999-08-26 | Schering Corp | Senyawa-senyawa trisiklik yang berguna untuk penghambatan fungsi protein-g dan untuk pengobatan penyakit-penyakit proliferatif |
TW492957B (en) * | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
ZA9711092B (en) | 1996-12-11 | 1999-07-22 | Smithkline Beecham Corp | Novel compounds. |
JPH1171345A (ja) * | 1997-08-30 | 1999-03-16 | Nippon Nohyaku Co Ltd | 光学活性なピロリジン誘導体及びその中間体並びにそれらの製造法 |
US6310043B1 (en) | 1998-08-07 | 2001-10-30 | Governors Of The University Of Alberta | Treatment of bacterial infections |
GB9821503D0 (en) | 1998-10-02 | 1998-11-25 | Novartis Ag | Organic compounds |
WO2002004402A1 (fr) * | 2000-07-11 | 2002-01-17 | Banyu Pharmaceutical Co., Ltd. | Derives d'ester |
WO2003013526A1 (en) * | 2001-08-08 | 2003-02-20 | Merck & Co. Inc. | Anticoagulant compounds |
US7098331B2 (en) * | 2003-03-05 | 2006-08-29 | Targacept, Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
WO2007054777A1 (en) * | 2005-11-09 | 2007-05-18 | Orchid Chemicals & Pharmaceuticals Limited | Depletion of isomer in cephalosporin antibiotic |
CN101490052B (zh) * | 2006-05-12 | 2012-08-08 | 美瑞德生物工程公司 | 治疗性化合物及其在癌症中的用途 |
-
2009
- 2009-11-25 TW TW098140046A patent/TW201024283A/zh unknown
- 2009-11-30 NZ NZ593058A patent/NZ593058A/xx not_active IP Right Cessation
- 2009-11-30 MX MX2011005712A patent/MX2011005712A/es not_active Application Discontinuation
- 2009-11-30 UY UY0001032278A patent/UY32278A/es not_active Application Discontinuation
- 2009-11-30 AU AU2009322628A patent/AU2009322628A1/en not_active Abandoned
- 2009-11-30 CA CA2744197A patent/CA2744197A1/en not_active Abandoned
- 2009-11-30 ES ES09775409T patent/ES2403022T3/es active Active
- 2009-11-30 KR KR1020117014805A patent/KR20110094318A/ko not_active Application Discontinuation
- 2009-11-30 MY MYPI2011002085A patent/MY159040A/en unknown
- 2009-11-30 BR BRPI0922152-2A patent/BRPI0922152A2/pt not_active IP Right Cessation
- 2009-11-30 EA EA201170736A patent/EA021054B1/ru not_active IP Right Cessation
- 2009-11-30 UA UAA201108205A patent/UA106217C2/ru unknown
- 2009-11-30 BR BRPI0922630A patent/BRPI0922630A2/pt not_active IP Right Cessation
- 2009-11-30 AU AU2009322630A patent/AU2009322630A1/en not_active Abandoned
- 2009-11-30 SG SG2011038528A patent/SG171432A1/en unknown
- 2009-11-30 CA CA2744191A patent/CA2744191A1/en not_active Abandoned
- 2009-11-30 EP EP09775409A patent/EP2358670B1/en active Active
- 2009-11-30 WO PCT/US2009/066083 patent/WO2010065447A2/en active Application Filing
- 2009-11-30 JP JP2011538712A patent/JP5698673B2/ja active Active
- 2009-11-30 CL CL2009002145A patent/CL2009002145A1/es unknown
- 2009-11-30 KR KR1020117014918A patent/KR20110094100A/ko active Search and Examination
- 2009-11-30 US US13/125,892 patent/US8633227B2/en not_active Expired - Fee Related
- 2009-11-30 CN CN200980148072.8A patent/CN102232072B/zh not_active Expired - Fee Related
- 2009-11-30 MX MX2011005713A patent/MX2011005713A/es active IP Right Grant
- 2009-11-30 WO PCT/US2009/066092 patent/WO2010065449A1/en active Application Filing
- 2009-11-30 US US13/130,954 patent/US8153821B2/en active Active
- 2009-11-30 JP JP2011538713A patent/JP5615836B2/ja not_active Expired - Fee Related
- 2009-11-30 RU RU2011127004/04A patent/RU2507197C2/ru active IP Right Revival
- 2009-11-30 CN CN2009801478569A patent/CN102227406B/zh not_active Expired - Fee Related
- 2009-11-30 CL CL2009002146A patent/CL2009002146A1/es unknown
- 2009-11-30 SG SG2011039575A patent/SG171876A1/en unknown
- 2009-11-30 EP EP14191551.2A patent/EP2896619A1/en not_active Withdrawn
- 2009-11-30 EP EP09775410A patent/EP2358705A1/en not_active Withdrawn
- 2009-11-30 PE PE2009001282A patent/PE20100467A1/es not_active Application Discontinuation
- 2009-11-30 AR ARP090104608A patent/AR074239A1/es not_active Application Discontinuation
- 2009-12-05 SA SA109300715A patent/SA109300715B1/ar unknown
-
2011
- 2011-05-09 IL IL212796A patent/IL212796A0/en unknown
- 2011-05-09 IL IL212799A patent/IL212799A/en not_active IP Right Cessation
- 2011-05-12 ZA ZA2011/03497A patent/ZA201103497B/en unknown
- 2011-06-16 EC EC2011011135A patent/ECSP11011135A/es unknown
- 2011-06-17 CO CO11075843A patent/CO6382158A2/es active IP Right Grant
- 2011-11-15 HK HK11112323.0A patent/HK1157778A1/xx unknown
-
2013
- 2013-12-16 US US14/107,175 patent/US20140107163A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6382158A2 (es) | Síntesis de novedosas formas de sales de (r)-3-((e)-2-(pirrolidin-3-il)vinil)-5-(tetrahidropiran-4-iloxi)piridina | |
CL2013002007A1 (es) | Compuesto polimorfo (s)-3-(1-(9h-purin-6-ilamino)etil)-8-cloro-2-fenilisoquinolin-1-(2h)-ona de formas b-j, amorfa, sal, solvato o hidrato del mismo; mezclas de estos compuestos; metodo para preparar el polimorfo de forma c; composicion farmaceutica; metodo de tratamiento; uso para el tratamiento de un trastorno mediado por pi3k. | |
DOP2015000158A (es) | Inhibidores de prmt5 y sus usos | |
EA200970806A1 (ru) | Сокристаллы и содержащие их фармацевтические композиции | |
MX2010008469A (es) | Pirazolopirimidinas, procedimiento para su preparacion y su uso como medicina. | |
MY148253A (en) | Azaadamantane derivatives and methods of use | |
UY32096A (es) | Derivados de 2-carboxamida - cicloamino - urea especìficos, sus sales farmacèuticamente aceptables, composiciones contenièndolos, pro-farmacos de los mismos, procesos para su produciòn y aplicaciones | |
MX2012003343A (es) | Proceso para preparar compuestos azabiciclicos. | |
UY31084A1 (es) | Compuestos de azaindol para la inhibicion de b-secretasa | |
MX2014000536A (es) | Compuestos de 4-piperidinilo para usarse como inhibidores de tanquirasa. | |
MX2010002902A (es) | Pirimidinas anti-infecciosas y usos de las mismas. | |
UY32156A (es) | Derivados sustituidos de la n2 - [1-(5 - fluoropirimidin -2-il) etil] - n4 - (1-metil - 1h-imidazol - 4 - il)) - pirimidina - 2,4 - diaminas y sus sales farmacéuticamente aceptables, proceso de preparación, composiciones conteniéndolos y aplicaciones. | |
CO7350641A2 (es) | Compuestos de 2-fenil-5-heterociclil-tetrahidro-2h-piran-3-amina para uso en el tratamiento de diabetes y sus trastornos asociados | |
MX2010002899A (es) | Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3. | |
MY146084A (en) | Benzyl amines, a process for their production and their use as anti-inflammatory agents | |
MY160392A (en) | Triptolide prodrugs | |
MX2009011149A (es) | Ligandos de receptor de vainilloide novedosos y el uso de los mismos para la produccion de sustancias farmaceuticas. | |
BRPI0916544A2 (pt) | Rotas de síntese para 2(s), 4(s), 5(s), 7(s) - 2, 7 dialquil-4-hidroxi-2-amino-8-aril-octanoil amida | |
ECSP11011167A (es) | Síntesis y formas de sales novedosas de (r) -5- ( (e) -2- (pirrolidin-3-ilvinil) pirimidina | |
ECSP13012548A (es) | Inhibidores de oxadiazol de la producción de leucotrienos. | |
CL2008001131A1 (es) | Solucion de manoproteinas; proceso para producir dicha solucion de manoproteinas; proceso para estabilizar vino impidiendo o retardando la cristalizacion de sales de acido tartarico. | |
BR112012013582A2 (pt) | processo para síntese de intermediários úteis para a produção de compostos de indazol e azaindazol substituídos | |
PE20091344A1 (es) | Arilindenopirimidinas como antagonistas del receptor a2a de adenosina | |
AR066086A1 (es) | Derivados de dihidro-benzo (b)(1,4)diazepin-2-ona-sulfonamida | |
SE0701694L (sv) | Nya bronkdilaterande a,b-omättade amider |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |